Entera Bio Ltd. (ENTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 80K 160K 240K Q3 '24: 99K Q4 '24: 181K Q1 '25: 223K Q2 '25: 166K Q3 '25: 124K Q4 '25: 42K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 3.5K 7K 10.5K Q3 '24: 9K Q4 '24: 9K Q1 '25: 9K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q3 '24: -9.2M Q4 '24: -9.6M Q1 '25: -10.1M Q2 '25: -10.6M Q3 '25: -10.8M Q4 '25: -11.5M Q1 '26: -12.5M Q2 '26: -14.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-18M -12M -6M 0 6M 12M 18M Q3 '24: -9.2M Q4 '24: -9.5M Q1 '25: -10.1M Q2 '25: -10.6M Q3 '25: -10.8M Q4 '25: -11.4M Q1 '26: -12.4M Q2 '26: -17M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 80K 160K 240K Q3 '24: 90K Q4 '24: 172K Q1 '25: 214K Q2 '25: 166K Q3 '25: 124K Q4 '25: 42K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q3 '24: -8M Q4 '24: -6.8M Q1 '25: -6.4M Q2 '25: -6.7M Q3 '25: -7M Q4 '25: -7.4M Q1 '26: -9.1M Q2 '26: -10.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q3 '24: -8M Q4 '24: -6.8M Q1 '25: -6.4M Q2 '25: -6.7M Q3 '25: -7.1M Q4 '25: -7.5M Q1 '26: -9.2M Q2 '26: -11M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 36.7M Q2 '24: 37.1M Q3 '24: 37.6M Q1 '25: 43.4M Q2 '25: 46.8M Q3 '25: 47.1M Q1 '26: 47.8M Q2 '26: 50.5M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.15 0.30 0.45 Q3 '24: 0.26 Q4 '24: 0.25 Q1 '25: 0.26 Q2 '25: 0.26 Q3 '25: 0.25 Q4 '25: 0.26 Q1 '26: 0.27 Q2 '26: 0.35 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.